ddp4 inhibitor and glp 1 agonist dpp-4_inhibitors [TUSOM Renoprotective Effects of DPP-4 Inhibitors
Description
Novel distribution revealed with extensively validated monoclonal antibody
Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity
The company also promised to manufacture the drug in the U.S.
But thats not really true
Conflicts of interest Novo Nordisk markets liraglutide for the treatment of diabetes
N Engl J Med 2021;385:896-907.ArticlePubMed 72
